Iron metabolism in K562 erythroleukemic cells

Area of Science:

• Cellular Metabolism
• Iron Homeostasis
• Heme Synthesis

Background:

• Iron uptake is crucial for cellular functions, including heme synthesis.
• Transferrin receptors mediate cellular iron uptake.
• Desferrioxamine is an iron chelator that can influence iron metabolism.

Purpose of the Study:

• To investigate the mechanism by which desferrioxamine enhances iron delivery to K562 cells.
• To elucidate the role of iron metabolism and heme synthesis in regulating cellular iron uptake.
• To determine whether a chelatable intracellular iron pool or heme synthesis regulates iron uptake.

Main Methods:

• K562 cells were treated with desferrioxamine, succinylacetone, or exogenous hemin.
• Iron uptake from iron-transferrin was measured.
• Incorporation of iron into ferritin and heme was quantified.
• Transferrin binding was assessed.

Main Results:

• Desferrioxamine treatment led to a 14-fold increase in intracellular desferrioxamine and inhibited iron incorporation into ferritin (86%) and heme (75%).
• Inhibition of heme synthesis with succinylacetone did not affect transferrin binding or iron uptake.
• Exogenous hemin inhibited transferrin binding and iron uptake (70%) and heme synthesis (90%).
• Cellular iron uptake was enhanced only by the intracellular iron chelator, desferrioxamine.

Conclusions:

• A chelatable intracellular iron pool, rather than heme synthesis, mediates the regulation of iron uptake in K562 cells.
• Desferrioxamine enhances iron uptake by inducing transferrin receptors.
• The effects of exogenous hemin on iron uptake are likely unphysiological.